Topics
Subscribe for Free
Your Host
Resources
- FREE E-newsletter
- Health Literacy “How To”
- Health Literacy Articles
- Health Literacy Consulting
- Health Literacy Month
HLOL Archives
- August 2010 (2)
- July 2010 (2)
- June 2010 (2)
- May 2010 (2)
- April 2010 (2)
- March 2010 (2)
- February 2010 (1)
- January 2010 (2)
- December 2009 (1)
- November 2009 (2)
- October 2009 (4)
- September 2009 (2)
- August 2009 (2)
- July 2009 (1)
- June 2009 (1)
- May 2009 (2)
- April 2009 (1)
- March 2009 (2)
- February 2009 (2)
- January 2009 (2)
- December 2008 (2)
- November 2008 (2)
- October 2008 (2)
- September 2008 (1)
Books by Helen Osborne
Mark Gibson MA is a Consumer Information Specialist based in Leeds, England. He is a linguist, translator, and journalist who now focuses on readability testing and information design. Building on his research in patient communication, Mark designs information that is appropriate for diverse audiences – including those with limited English proficiency, low literacy skills, and sight loss.
In this podcast he compares and contrasts ways to assess readability in the European Union (EU) and the United States. Topics include:
- Assessing readability: How does the system used in the EU compare to that in the United States?
- EU process of assessing readability: What works well and what does not?
- Lessons learned and resources that listeners can use right away.
More Ways to Learn:
- Mark Gibson’s business is RiW Design Ltd, www.riw-design.com You can contact him directly by email at mark@gibsonrs.eu
- Gibson M, Hochhauser M. “Readability Testing: European Performance vs USA Formulas,” SoCRA Source: A Publication of the Society of Clinical Research Associates. May 2010:69-71.
- Sless D, Wiseman R. Writing About Medicines for People. Canberra: Australian Government Publishing Service, 1997
- Guideline on the Readability of the Labelling and Package Leaflet of Medicinal Products for Human Use, European Medicines Agency, Revision 1, 12 January 2009. Available at http://ec.europa.eu/enterprise/sectors/pharmaceuticals/files/eudralex/vol-2/c/2009_01_12_readability_guideline_final_en.pdf [last accessed 09Jun2010]
No Comments »
No comments yet.
RSS feed for comments on this post.



